These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2095207)

  • 21. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
    Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
    Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of an individual specific small cell lung carcinoma associated antigen.
    Bosslet K; Lüben G; Stark M; Sedlacek HH
    Behring Inst Mitt; 1985 Dec; (78):133-8. PubMed ID: 2421709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
    Lewis MR; Shively JE
    Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
    Giacomini P; Natali P; Ferrone S
    J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
    Trail PA; Willner D; Knipe J; Henderson AJ; Lasch SJ; Zoeckler ME; TrailSmith MD; Doyle TW; King HD; Casazza AM; Braslawsky GR; Brown J; Hofstead SJ; Greenfield RS; Firestone RA; Mosure K; Kadow KF; Yang MB; Hellström KE; Hellström I
    Cancer Res; 1997 Jan; 57(1):100-5. PubMed ID: 8988048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
    Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
    Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety.
    Bargiotti A; Casazza AM; Cassinelli G; Di Marco A; Penco S; Pratesi G; Supino R; Zaccara A; Zunino F; Arcamone F
    Cancer Chemother Pharmacol; 1983; 10(2):84-9. PubMed ID: 6831630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant human B cells express two populations of p24 surface antigens.
    Pesando JM; Hoffman P; Conrad T
    J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of tumor cell growth in vitro by murine monoclonal antibodies that recognize a proliferation-associated cell surface antigen system in rats and humans.
    Yagita H; Masuko T; Hashimoto Y
    Cancer Res; 1986 Mar; 46(3):1478-84. PubMed ID: 2417704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rodorubicin, a new tetraglycosidic anthracycline.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1988 Apr; (82):216-30. PubMed ID: 3165634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal mouse antibodies raised against human lung carcinoma.
    Hellström I; Horn D; Linsley P; Brown JP; Brankovan V; Hellström KE
    Cancer Res; 1986 Aug; 46(8):3917-23. PubMed ID: 3731064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of the monoclonal antibody to cultured uterine endometrial adenocarcinoma cells (EI)].
    Yudate T; Isaka K; Okabe K; Takayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):635-42. PubMed ID: 7636334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
    Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
    Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
    Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
    J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-group antigen expression during pancreatic cancer induction in hamsters.
    Pour PM; Uchida E; Burnett DA; Steplewski Z
    Int J Pancreatol; 1986 Dec; 1(5-6):327-40. PubMed ID: 3316427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.
    Griffiths GL; Mattes MJ; Stein R; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Dec; 9(17):6567-71. PubMed ID: 14695162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic modulation induced by four monoclonal antibodies adsorbed on gold particles (specificity anti-CD4, anti-CD5, anti-CD7, and anti-150-kDa antigen): relationship between modulation and cytotoxic activity of immunotoxins.
    Carriere D; Arcier JM; Derocq JM; Fontaine C; Richer G
    Exp Cell Res; 1989 May; 182(1):114-28. PubMed ID: 2785456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ring-B modified anthracyclines.
    Suarato A; Angelucci F; Geroni C
    Curr Pharm Des; 1999 Mar; 5(3):217-27. PubMed ID: 10066891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.